• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Contrave

Currax Pharmaceuticals Contrave Cravings Dont Own Me campaign
Marketing

Currax's first Contrave TV ad claims 'Cravings Don't Own Me'

Currax Pharmaceuticals is kicking off the new year with a new direct-to-consumer campaign for its weight loss medication Contrave.
Andrea Park Jan 2, 2025 2:30pm
Currax Pharmaceuticals Stop the Food Noise campaign

Weight loss drug maker Currax runs campaign against food noise

Sep 24, 2024 12:36pm
A person stepping onto a scale

Currax launches Contrave 'One Size Does Not Fit All' campaign

Aug 31, 2022 9:38am
FDA Building 2

FDA ad watchdog slaps 2 pharmas with warning letters

Oct 7, 2020 10:25am
eisai

Eisai obesity drug Belviq picks up heart-safety edge

Jul 18, 2018 10:28am
Handshake business deal executives

Pernix and co. ink $75M deal to put Orexigen out of its misery

Apr 24, 2018 12:30pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings